These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15514407)

  • 1. Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Am J Psychiatry; 2004 Nov; 161(11):2060-5. PubMed ID: 15514407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition.
    Bruijn JA; Moleman P; Mulder PG; van den Broek WW
    J Clin Psychiatry; 1998 Dec; 59(12):657-63. PubMed ID: 9921699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2006 Feb; 67(2):263-8. PubMed ID: 16566622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.
    Nemeroff CB; Evans DL; Gyulai L; Sachs GS; Bowden CL; Gergel IP; Oakes R; Pitts CD
    Am J Psychiatry; 2001 Jun; 158(6):906-12. PubMed ID: 11384898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
    Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
    Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine.
    Koetsier GC; Volkers AC; Tulen JH; Passchier J; van den Broek WW; Bruijn JA
    J Psychiatr Res; 2002; 36(6):391-7. PubMed ID: 12393308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
    Gómez Gómez JM; Teixidó Perramón C
    J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
    Vermeiden M; van den Broek WW; Mulder PG; Birkenhäger TK
    J Psychopharmacol; 2010 Apr; 24(4):497-502. PubMed ID: 19423613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium addition to a tricyclic antidepressant results in optimal efficacy.
    Birkenhäger TK; Van Den Broek WW
    Acta Psychiatr Scand; 2011 Jan; 123(1):83; author reply 83. PubMed ID: 20880071
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.
    Tignol J; Pujol-Domenech J; Chartres JP; Léger JM; Plétan Y; Tonelli I; Tournoux A; Pezous N
    Acta Psychiatr Scand; 1998 Feb; 97(2):157-65. PubMed ID: 9517912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S; Möller HJ; Montgomery SA; Zondag E
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder.
    Volkers AC; Tulen JH; Van Den Broek WW; Bruijn JA; Passchier J; Pepplinkhuizen L
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):273-8. PubMed ID: 12126865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
    J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.